0.00Open0.25Pre Close0 Volume0 Open Interest0.50Strike Price0.00Turnover0.00%IV-80.11%PremiumMay 17, 2024Expiry Date3.27Intrinsic Value100Multiplier-5DDays to Expiry0.00Time Value100Contract SizeAmericanOptions Type--Delta--Gamma15.08Leverage Ratio--Theta--Rho--Eff Leverage--Vega
NRX Pharmaceuticals Stock Discussion
Catching the attention of the pharmaceutical industry and investors alike, NRx Pharmaceuticals (Nasdaq: NRXP), a clinical-stage pharmaceutical company, has announced final clinical trial results showcasing a superior safety profile of NRX-101 over lurasidon...
NRX Pharmaceuticals (Nasdaq:Nrxp) Announces Final Clinical Trial Results: Superior Safety Combined With Similar Efficacy in the Trial of NRX-101 Compared to Lurasidone in Suicidal Bipolar Depression
No comment yet